Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132712) titled 'Investigation of immuneregulating methods for preventing and treating emerging and reemerging infectious diseases' on Sept. 17.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shanghai General Hospital
Condition:
Emerging, Reemerging and Major Infectious Diseases
Recruitment Status: Not Recruiting
Phase: 4
Date of First Enrollment: 2026-09-29
Target Sample Size: Observation group:90;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=341068
Published by HT Digital Content Services with permission from Health Daily Digest....